Your browser doesn't support javascript.
loading
[Clinical and economic consequences in patients initiating therapy with clopidogrel brand-name vs. generic: A real-life retrospective study]. / Consecuencias clínicas y económicas en pacientes que inician tratamiento con clopidogrel de marca vs. genérico: estudio retrospectivo de vida real.
Sicras-Mainar, A; Escobar-Cervantes, C; Micó-Pérez, R M; Llisterri-Caro, J L.
Affiliation
  • Sicras-Mainar A; Dirección Científica, HEOR, Real Life Data, Madrid, España. Electronic address: antoni.sicras@rlifedata.com.
  • Escobar-Cervantes C; Servicio de Cardiología, Hospital Universitario La Paz, Madrid, España.
  • Micó-Pérez RM; Consultorio Fontanars dels Alforins, EAP Ontinyent, Valencia, España.
  • Llisterri-Caro JL; Fundación de Investigación SEMERGEN, Madrid, España.
Semergen ; 46(1): 16-26, 2020.
Article in Es | MEDLINE | ID: mdl-31345684
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Drugs, Generic / Acute Coronary Syndrome / Peripheral Arterial Disease / Clopidogrel Type of study: Health_economic_evaluation / Observational_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: Es Journal: Semergen Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Drugs, Generic / Acute Coronary Syndrome / Peripheral Arterial Disease / Clopidogrel Type of study: Health_economic_evaluation / Observational_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: Es Journal: Semergen Year: 2020 Document type: Article